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COMPLICATIONS 
Pathologic Analysis of Recurrent Posttransplant 
Lymphoproliferative Disorders 
T.-T. Wu, S. Swerdlow, J. Locker, P.S. Randhawa, E. Yunis, J. Reyes, J.J. Fung, T.E. Starzl, 
and MA Nalesnik 
POSITRANSPLANT lymphoproliferative disorders (PTLDs) are a family of lesions that may become 
clinically manifest at different stages of progression. 1-4 The 
histopathology of this disorder ranges from a polyclonal 
lymphoproliferation resembling infectious mononucleosis 
to a monoclonal disorder most frequently resembling non-
Hodgkin's lymphoma. The Epstein-Barr virus (EBV) is 
detectable in the overwhelming majority of PTLDs and 
current theories invoke the virus as an important factor in 
the development of these lesions. However. even with 
successful treatment of PTLD. the natural history of the 
underlying EBV infection. that is. lifelong persistence of 
latent virus. remains unchanged. Thus. these patients re-
main at risk for the development of complications associ-
ated with EBV infection. 
We reviewed the Pittsburgh transplant patient series to 
determine the number of patients who developed clinical 
recurrence of PTLD and evaluated histologic, clonal. and 
viral features to determine the relationship between pri-
mary and recurrent lesions. 
MATERIALS AND METHODS 
Surgical Pathology files at the University of Pittsburgh Medical 
Center Hospitals (Presbyterian University Hospital. Children's 
Hospital of Pittsburgh. and Montefiore University Hospital) were 
reviewed to detect patients who had evidence of two or more 
episodes of PTID. Only patients who had documented clinical 
remission were included. Those with incomplete regression of mass 
lesions or persistent clinical symptoms were excluded. Pathologic 
slides were reviewed. PTIDs were categorIzed as polymorphic or 
monomorphic based on previously defined criteria:' In addition. 
those cases with a picture of infectious mononucleosis were distin-
guished from these categories. Immunoglobulin gene rearrange-
ment studies and evaluations of T cell receptor beta chain rear-
rangements and of EBV presence and clonality were performed as 
previously described.· 
RESULTS 
Eleven patients with clinical recurrence of PTLD were 
identified. Three patients had a histologically similar recur-
rence (1M-like, polymorphic and monomorphic PTLD). In 
two cases identical clones of B cells were identified in the 
primary and second lesions. Three patients evolved from 
1M-like lesions to polymorphic PTLDs. One of these pa-
tients developed a clonal B-cell population that was not 
present in the first specimen. Five patients who initially had 
a polymorphic PTLD developed morphologically dissimilar 
EBV-associated lesions that had widely divergent histologic 
appearances. 
DISCUSSION 
This series underscores the diversity of lesions that fall 
under the general heading of PTLD. Clinical recurrence of 
this syndrome may occur and may be due to relapse of the 
original lesion or to the development of a tumor that is 
distinguishable on both histologic and clonal levels from the 
primary lesion. This latter category is of particular interest 
from a pathogenetic standpoint. In one case, the original 
and second lesions contained different clonal populations of 
EBV in addition to different immunoglobulin gene rear-
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rangement patterns. This suggests that these two clones 
were unrelated. The possibility that the second lesion arose 
from a cryptic clone in the first tumor cannot be ruled out 
by the present studies. 
The diversity of EBV-positive tumors in this series also 
points out the limitations of designating all such complica-
tions of EBV infection as PTLD or. worse, as transplant 
lymphomas. Patients with PTLD recurrence may provide 
unique insights into the evolution of this disease. Infectious 
mononucleosis and polymorphic PTLD are likely to be 
closely related processes that may differ in the extent of 
architectural destruction, degree of clonal outgrowth. and 
possibly other factors undefined at present. In some cases 
the distinction between these two complications of EBV 
infection may be difficult if not impossible to make on a 
morphologic basis alone. Monomorphic EBV-positive neo-
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plasms indistinguishable from high-grade lymphomas rep-
resent a less common and more advanced form of disease 
and should be distinguished from the preceding categories. 
Efforts to establish a classification system incorporating our 
current understanding of the evolution of this disease will 
provide a rational foundation on which to study frequency 
data and to evaluate the efficacies of different therapeutic 
strategies. 
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